Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease. [PDF]
Yan A +9 more
europepmc +1 more source
Purpose: Immunologic principles behind antigen presentation inform the pathophysiologic basis of adverse cutaneous drug eruptions (ACDEs). We hypothesize that HIV predisposes to Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN), a severe ...
Guerra, Ricardo
core
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions. [PDF]
James F +54 more
europepmc +1 more source
Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients. [PDF]
Phillips GS +11 more
europepmc +1 more source
Fixed Drug Eruptions Due To/Caused by Levocetirizine and Cetirizine: An Uncommon Adverse Cutaneous Drug Reaction to Commonly Used Piperazine Derivatives. [PDF]
Tyagi M +5 more
europepmc +1 more source
Autoimmune sequelae in severe drug eruptions [PDF]
Aoyama Y +7 more
europepmc +1 more source
Variants of Fixed Drug Eruptions Following Covid-19 Vaccination: A Series of Three Cases.
Saraswat N +4 more
europepmc +1 more source
Fixed-drug Eruptions: What can we Learn from a Case Series?
Jhaj R +3 more
europepmc +1 more source

